Health Condition 1: H409- Unspecified glaucoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: DIAGNOSED CASES OF GLAUCOMA (PRIMARY OPEN ANGLE, ANGLE CLOSURE, PSEUDOEXFOLIATION, PIGMENTARY GLAUCOMA) ON TOPICAL ANTIGLAUCOMA MEDICATIONS FOR MORE THAN 6 MONTHS WILLINGNESS TO PROVIDE WRITTEN INFORMED CONSENT. SUBJECTS NOT USING ANY TOPICAL OCULAR MEDICATIONS
Exclusion criteria
Exclusion criteria: USE OF TOPICAL STEROIDS OR LUBRICANTS HISTORY OF OCULAR SURGERY SECONDARY GLAUCOMA (E.G., UVEITIC, LENS-INDUCED) CONTACT LENS USERS KNOWN SYSTEMIC DISEASES AFFECTING TEAR FILM (E.G., SJOGRENS SYNDROME)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TO IDENTIFY CLINICAL AND DEMOGRAPHIC RISK FACTORS (E.G., AGE, COMORBIDITIES, POLYPHARMACY) ASSOCIATED WITH OCULAR SURFACE DISEASES IN GLAUCOMA PATIENTS.Timepoint: 1ST DAY & 15TH DAY | — |
Secondary
| Measure | Time frame |
|---|---|
| TO DETERMINE THE PREVALENCE AND SEVERITY OF OSD IN GLAUCOMA PATIENTS (EG- USING OSDI (OCULAR SURFACE DISEASES INDEX), TBUT(TEAR BREAKUP TIME), SCHIRMER S TEST, AND LISSAMINE GREEN STAINING). TO COMPARE THESE FINDINGS WITH HEALTHY CONTROLS. TO ASSESS THE CORRELATION BETWEEN OSD (OCULAR SURFACE DISEASES) SEVERITY AND NUMBER/DURATION OF ANTIGLAUCOMA MEDICATIONS. TO ASSESS THE IMPACT OF PRESERVATIVE-CONTAINING VERSUS PRESERVATIVE-FREE FORMULATIONS ON OCULAR SURFACE PARAMETERS. TO EXPLORE TREATMENT PATTERNS AND GAPS IN THE CURRENT MANAGEMENT OF OSD IN GLAUCOMATimepoint: 1ST & 15TH DAY | — |
Countries
India
Contacts
Datta Meghe Institute Of Higher Education And Research